MedTrace Logo

Gestational Response, Outcomes, and Weight After GLP-1 Use

NCT07743567 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2026-08-04

No results posted yet for this study

Summary

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to:

* Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure.
* Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure.

Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences.

Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

Conditions

  • Pregnant Individuals
  • Obesity & Overweight
  • Gestational Weight Gain

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-13
Primary Completion
2028-04-30
Completion
2028-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07743567 on ClinicalTrials.gov